Stay updated with breaking news from Indigo System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Penumbra, Inc. (NYSE:PEN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine research firms that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month […]
Shares of Penumbra, Inc. (NYSE:PEN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year price target among analysts […]
Founded in 2004, Penumbra has grown into a global healthcare company specializing in innovative therapies. With over 4000 employees, the company offers products in more than 100 markets worldwide....
Penumbra, Inc. (NYSE:PEN – Get Free Report) Director Don W. Kassing sold 170 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $223.18, for a total transaction of $37,940.60. Following the completion of the transaction, the director now directly owns 1,175 shares in the […]
Penumbra, Inc. (NYSE:PEN – Get Free Report) Director Don W. Kassing sold 170 shares of the firm’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $223.18, for a total value of $37,940.60. Following the completion of the sale, the director now directly owns 1,175 shares in […]